Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (0.22%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Trading Update

12 Nov 2015 07:00

RNS Number : 4277F
Morgan Advanced Materials PLC
12 November 2015
 



 

Press Release

Trading Update

Morgan Advanced Materials plc

12th November 2015

 

 

Morgan Advanced Materials plc, the advanced materials company, is today issuing the following trading update covering the period from 1st July 2015 to 11th November 2015.

 

Trading conditions in the period since the half year have weakened across the Group with North America and China particularly affected by deteriorating demand. Overall our order book has mirrored this weakness, but with a mixed profile across the geographies, businesses and end markets in which we operate.

 

At the end of October the YTD book to bill ratio was 1.00 (June 2015 -1.03). The outstanding order book at the end of October was 5.3% below last year (June 2015 - 5.7% higher than the June 2014). Given this order profile, the Group expects that reported revenue in the second half of the year will be c7% below the first half of 2015 and that EBITA before restructuring and one-offs will be around the lower end of the range of analyst expectations.

 

The North American region has been the most affected by economic slowdown. General industrial demand weakness has been seen across our business over the last four months particularly oil and gas, transportation and mining markets.

 

In Europe the Thermal Ceramics business has continued to trade well, offset by weak demand in Technical Ceramics, Seals and Bearings and Composites and Defence Systems.

 

Asia/ROW has continued to see very weak demand in China, which has impacted both the products manufactured in-region for industrial markets and also those sold in to China from Morgan businesses in North America and Europe. The rest of Asia has shown some weakness in parts of its demand environment, but overall has been fairly resilient. Weak economic conditions in South America, particularly in Brazil and Argentina, are impacting the performance of our mainly industrial business in the region.

 

The Group is cautious about the trading and macro-economic environment for the rest of this year, and into 2016, and the Group has undertaken a range of cost reduction measures in line with this weakening economic environment and will continue to take further action as necessary. The cash cost for these restructuring and one-off items is estimated to be low, in the region of £3 million. Against this challenging market, the Group continues to invest in R&D and profitable growth opportunities which are critical for the future. Such investment is underpinned by solid cash flow and a strong balance sheet, with low net debt estimated to be c1.5 times EBITDA at the end of 2015.

 

Morgan's preliminary results for the year ended 31st December 2015 will be announced on 23rd February 2016.

 

(Note:

Current market expectations compiled from analyst notes for EBITA before restructuring and one-off items range from £110.0 million to £121.5 million).

 

 

 

 

 

 

For further enquiries:

 

Pete Raby/Kevin Dangerfield

Morgan Advanced Materials plc

01753 837000

Mike Smith/Nina Coad

Brunswick

0207 404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKDDDFBDDODD
Date   Source Headline
28th Apr 20209:15 amRNSDisclosure of Rights Attached to Listed Securities
9th Apr 20201:33 pmRNSNotice of AGM
2nd Apr 20205:01 pmRNSDirector/PDMR Shareholding
1st Apr 20201:04 pmRNSAnnual Financial Report
31st Mar 20207:00 amRNSCOVID-19 Update
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:39 pmRNSPrice Monitoring Extension
19th Mar 202012:22 pmRNSDirector/PDMR Shareholding
12th Mar 202010:14 amRNSDirector/PDMR Shareholding
11th Mar 202010:57 amRNSDirector/PDMR Shareholding
3rd Mar 20205:29 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSFull-year Results
16th Dec 20199:10 amRNSBlock listing Interim Review
2nd Dec 20199:10 amRNSDirector Declaration
18th Nov 201911:00 amRNSDirector/PDMR Shareholding
13th Nov 20199:48 amRNSDirector/PDMR Shareholding
12th Nov 201912:23 pmRNSDirector/PDMR Shareholding
11th Nov 20194:04 pmRNSDirector/PDMR Shareholding
11th Nov 20192:44 pmRNSDirector/PDMR Shareholding
8th Nov 20197:00 amRNSTrading Update
23rd Oct 20191:56 pmRNSHolding(s) in Company
23rd Oct 20191:54 pmRNSHolding(s) in Company
23rd Sep 201912:03 pmRNSDirector/PDMR Shareholding
3rd Sep 20192:21 pmRNSHolding(s) in Company
25th Jul 20197:00 amRNSHalf-year Report
17th Jun 20198:06 amRNSBlock listing Interim Review
7th Jun 20199:38 amRNSHolding(s) in Company
24th May 20191:08 pmRNSDirector/PDMR Shareholding
10th May 201912:14 pmRNSResult of AGM
10th May 20197:00 amRNSTrading Update
7th May 20194:36 pmRNSDirectorate Change
8th Apr 20195:29 pmRNSDirector/PDMR Shareholding
3rd Apr 201911:22 amRNSAnnual Financial Report
19th Mar 20199:47 amRNSDirector/PDMR Shareholding
19th Mar 20199:44 amRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFinal Results
17th Dec 201810:51 amRNSBlock listing Interim Review
21st Nov 20182:36 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSDivestment of Composites and Defence Systems
9th Nov 20187:00 amRNSTrading Update
22nd Oct 20185:17 pmRNSHolding(s) in Company
28th Sep 20188:17 amRNSCompletion of Bank Refinancing
6th Aug 20189:24 amRNSDirector/PDMR Shareholding
1st Aug 20188:54 amRNSDirector/PDMR Shareholding
26th Jul 20187:00 amRNSHalf-year results
2nd Jul 20182:37 pmRNS2017 Environmental, Health and Safety Report
2nd Jul 20187:00 amRNSDirectorate Change
15th Jun 20189:00 amRNSBlock listing Interim Review
11th May 20181:32 pmRNSResult of AGM
1st May 20182:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.